Ceradis Receives U.S. EPA Approval for New Biofungicide CeraMax

By Ceradis B.V.|11 November 2019

Ceradis B.V. has announced its first product registration in the U.S., with the EPA granting the registration of CeraMax for seed treatment of soybeans. CeraMax is a biofungicide with efficacy against a broad spectrum of fungal diseases. The first application of CeraMax will be as a seed treatment against the Sudden Death Syndrome, a fusarium disease on soybeans. This solution has proven excellent efficacy, at the same level as the best commercial chemical fungicides, against Sudden Death Syndrome. These findings were confirmed in three years of trials, spanning a swath of states in the U.S. Midwest.

CeraMax contains the active ingredient Natamycin. Natamycin is a biological molecule produced by soil bacteria as a defense mechanism against fungi. Natamycin is an approved food additive, that has been used for decades to preserve for example cheese. Natamycin is not only safe for human food, it is also safe for the crop and non-target organisms. This is due to its unique mode of action. It targets ergosterol, which only fungi possess. CeraMax is therefore a new tool to help farmers in the battle against resistance development.

Advertisement

Continue reading at Ceradis.

Ceradis B.V. develops and commercializes innovative, environmentally friendly crop protection products and formulations. A spin-off from Wageningen University & Research (Netherlands), Ceradis has developed and patented (biological) formulation technologies that boost the efficacy of existing chemical Active Ingredients, resulting in a reduced rate of chemicals use per hectare of farmland and lower residues on the crop, making them more environment friendly. See all author stories here.

Hide picture